Assignee profile:

ARGOS THERAPEUTICS, INC.

City:

Durham, North Carolina

Country:

United States

Published Applications:

41

Last publication date:

2017-04-06

Patent Grants:

39

Last grant date:

2019-01-22

Top Inventors for applications by ARGOS THERAPEUTICS, INC.

These are the the leading inventors for applications assigned to ARGOS THERAPEUTICS, INC.:

Recent patent applications by ARGOS THERAPEUTICS, INC.

ARGOS THERAPEUTICS, INC. based in Durham, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-04-06 βœ… Patent 10,184,108 granted on 2019-01-22
US20170096639A1
Chemistry; metallurgy

Mature dendritic cell compositions and methods for culturing same

#2 | 2017-03-09 βœ… Patent 9,638,707 granted on 2017-05-02
US20170067925A1
Physics

Methods of processing samples

#3 | 2016-11-10 βœ… Patent 9,527,074 granted on 2016-12-27
US20160326573A1
Chemistry; metallurgy

Processing containers

#4 | 2015-09-10 βœ… Patent 9,879,053 granted on 2018-01-30
US20150252083A1
Chemistry; metallurgy

Strain-independent amplification of pathogens and vaccines thereto

#5 | 2015-08-13 βœ… Patent 9,409,178 granted on 2016-08-09
US20150224506A1
Performing operations; transporting

Processing containers

#6 | 2015-08-11 βœ… Patent 9,102,726 granted on 2015-08-11
US10382397
Chemistry; metallurgy

Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same

#7 | 2015-03-12 βœ… Patent 9,556,455 granted on 2017-01-31
US20150072431A1
Chemistry; metallurgy

Mature dendritic cell compositions and methods for culturing same

#8 | 2015-03-05 βœ… Patent 9,732,140 granted on 2017-08-15
US20150065684A1
Chemistry; metallurgy

Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases

#9 | 2014-12-11 βœ… Patent 10,022,731 granted on 2018-07-17
US20140364296A1
Performing operations; transporting

Centrifuge vessels with a center mound and an internal elongate tube suitable for live cell processing and associated systems and methods

#10 | 2014-01-16 βœ… Patent 9,523,077 granted on 2016-12-20
US20140017788A1
Chemistry; metallurgy

Mature dendritic cell compositions and methods for culturing same

#11 | 2013-08-22 βœ… Patent 9,040,303 granted on 2015-05-26
US20130217105A1
Physics

Apparatus for measuring volume of a fluid

#12 | 2013-04-25 βœ… Patent 8,658,771 granted on 2014-02-25
US20130101602A1
Chemistry; metallurgy

Humanized antibodies against human interferon-alpha

#13 | 2012-12-27 βœ… Patent 10,006,901 granted on 2018-06-26
US20120328563A1
Physics

CD4CD25 regulatory T cells from human blood

#14 | 2012-11-29 βœ… Patent 8,574,901 granted on 2013-11-05
US20120301959A1
Chemistry; metallurgy

Cryoconserved mature dendritic cells

#15 | 2012-10-25 βœ… Patent 8,431,404 granted on 2013-04-30
US20120270310A1
Physics

Apparatus for transfer of liquid for processing samples

#16 | 2012-09-13 βœ… Patent 9,970,068 granted on 2018-05-15
US20120231509A1
Chemistry; metallurgy

Primers and probes for the amplification and detection of HIV GAG, REV and NEF polynucleotides

#17 | 2012-08-07 βœ… Patent 8,236,562 granted on 2012-08-07
US10362715
-

Method for producing ready to use, antigen-loaded or unloaded, cryoconserved mature dendritic cells

#18 | 2012-08-02 βœ… Patent 8,361,463 granted on 2013-01-29
US20120195888A1
Chemistry; metallurgy

Humanized antibodies against human interferon-alpha

#19 | 2012-07-17 βœ… Patent 8,222,033 granted on 2012-07-17
US10618134
-

CD4CD25T cells and Tr1-like regulatory T cells

#20 | 2012-05-10 βœ… Patent 8,501,470 granted on 2013-08-06
US20120114680A1
Chemistry; metallurgy

Dendritic cell compositions and methods

#21 | 2012-05-10 βœ… Patent 8,603,815 granted on 2013-12-10
US20120114597A1
Chemistry; metallurgy

CD4 CD25 T cells and Tr1-like regulatory T cells

#22 | 2012-01-26 βœ… Patent 8,211,701 granted on 2012-07-03
US20120021422A1
Physics

Methods for processing samples in a closed container

#23 | 2012-01-19 βœ… Patent 8,759,505 granted on 2014-06-24
US20120015890A1
Chemistry; metallurgy

Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases

#24 | 2011-09-01 βœ… Patent 8,163,885 granted on 2012-04-24
US20110213125A1
Chemistry; metallurgy

Humanized antibodies against human interferon-alpha

#25 | 2011-04-07 βœ… Patent 8,513,208 granted on 2013-08-20
US20110081327A1
Chemistry; metallurgy

Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection

#26 | 2010-06-03 βœ… Patent 8,221,981 granted on 2012-07-17
US20100136631A1
Chemistry; metallurgy

Primers and probes for the amplification and detection of HIV Gag, Rev and Nef polynucleotides

#27 | 2010-02-09 βœ… Patent 7,659,119 granted on 2010-02-09
US8600483
-

Method and compositions for obtaining mature dendritic cells

#28 | 2009-12-03 βœ… Patent 8,030,080 granted on 2011-10-04
US20090298129A1
Physics

Systems and methods for processing samples in a closed container, and related devices

#29 | 2009-09-10
US20090226404A1
Chemistry; metallurgy

Methods for Generating Antigen-Specific Effector T Cells

#30 | 2009-08-13 βœ… Patent 8,672,879 granted on 2014-03-18
US20090204071A1
Human necessities

Devices, systems and related methods suitable for delivery of a liquid medicament stored at cryogenic temperatures

#31 | 2009-02-26 βœ… Patent 8,153,425 granted on 2012-04-10
US20090053251A1
Chemistry; metallurgy

Dendritic cell compositions and methods

#32 | 2009-01-29 βœ… Patent 7,923,247 granted on 2011-04-12
US20090029469A1
Chemistry; metallurgy

Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens

#33 | 2008-12-18 βœ… Patent 9,085,807 granted on 2015-07-21
US20080311155A1
Human necessities

Strain-independent amplification of pathogens and vaccines thereto

#34 | 2007-11-08 βœ… Patent 8,076,134 granted on 2011-12-13
US20070258959A1
Chemistry; metallurgy

CD4+CD25βˆ’ T cells and Tr1-like regulatory T cells

#35 | 2007-10-25
US20070248578A1
Human necessities

Mrna Transfected Antigen Presenting Cells

#36 | 2007-09-13 βœ… Patent 8,124,099 granted on 2012-02-28
US20070212370A1
Chemistry; metallurgy

Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells

#37 | 2007-07-19 βœ… Patent 7,893,200 granted on 2011-02-22
US20070167607A1
Chemistry; metallurgy

Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases

#38 | 2007-04-12 βœ… Patent 8,513,008 granted on 2013-08-20
US20070082400A1
Chemistry; metallurgy

Mature dendritic cell compositions and methods for culturing same

#39 | 2007-04-03 βœ… Patent 7,198,948 granted on 2007-04-03
US10047072
-

Methods and compositions for obtaining mature dendritic cells

#40 | 2006-06-08 βœ… Patent 7,785,583 granted on 2010-08-31
US20060121003A1
Human necessities

In situ maturation of dendritic cells

#41 | 2006-04-13 βœ… Patent 8,822,223 granted on 2014-09-02
US20060078994A1
Chemistry; metallurgy

Mature dendritic cell compositions and methods for culturing same

Also check out Argos Therapeutics, Inc.'s (Durham, United States) applicant profile with 10 patent applications submitted.

AssigneeID:

19477 ⎘